Molecular diversity of cyclic AMP signalling

Frontiers in Neuroendocrinology

Volumn 21, Issue 2, 2000, Pages 103-132

  Antoni, Ferenc A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CALCINEURIN; CALCIUM ION; CALMODULIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; PHOSPHODIESTERASE; PROTEIN KINASE; PROTEIN KINASE C; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN;

ADENOHYPOPHYSIS; CATALYSIS; CELLULAR DISTRIBUTION; ENZYME ACTIVATION; ENZYME INHIBITION; HUMAN; NONHUMAN; PINEAL BODY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

EID: 0034011650     PISSN: 00913022     EISSN: None     Source Type: Journal    
DOI: 10.1006/frne.1999.0193     Document Type: Article

References (171)

1. Adams S, Bacskai B, Harootunian A T, Mahaut-Smith M, Sammak P J, Taylor S S, Tsien R Y. Imaging of cAMP signals and A-kinase translocation in single living cells. Adv Second Messenger Phosphoprotein Res. 28:1993;167-170.
2. Adler M, Wong B S, Sabol S L, Buis N, Jackson M B, Weight F F. Action potentials and membrane ion channels in clonal anterior pituitary cells. Proc Natl Acad Sci USA. 80:1983;2086-2090.
3. Ang, K-L, Differential Regulation of Cyclic Nucleotide Phosphodiesterases in Anterior Pituitary Cells. Ph.D. Thesis, University of Edinburgh, 1999.
4. Antaraki A, Ang K L, Antoni F A. Involvement of calyculin A inhibitable protein phosphatases in the cyclic AMP signal transduction pathway of mouse corticotroph tumour (AtT20) cells. Br J Pharmacol. 121:1997;991-999.
5. 2+ feedback inhibition of cAMP responses induced by 41-residue corticotrophin releasing-factor in acutely dispersed rat anterior pituitary cells. J Physiol (Lond). 499p:1997;19.
6. Antoni F A. Calcium checks cyclic AMP - Mechanism of corticosteroid feedback in adenohypophysial corticotrophs. J Neuroendocrinol. 8:1996;659-672.
7. Antoni F A. Calcium regulation of adenylyl cyclase - Relevance for endocrine control. Trends Endo Metab. 8:1997;7-13.
8. Antoni F A. Hypothalamic regulation of adrenocorticotropin secretion: Advances since the discovery of 41-residue corticotropin-releasing factor. Endocr Rev. 7:1986;351-378.
9. Antoni F A. Receptors mediating the CRH effects of vasopressin and oxytocin. Ann N Y Acad Sci. 512:1987;195-204.
10. Antoni F A. Vasopressin and the endocrine response to stress. Neth J Zool. 45:1995;98-102.
11. Antoni F A. Vasopressinergic control of anterior pituitary adrenocorticotropin secretion comes of age. Front Neuroendocrinol. 14:1993;76-122.
12. Antoni F A, Barnard R JO, Shipston M J, Smith S M, Simpson J, Paterson J M. Calcineurin feedback inhibition of agonist-evoked cAMP formation. J Biol Chem. 270:1995;28,055-28,061.
13. Antoni F A, Hoyland J, Woods M D, Mason W T. Glucocorticoid inhibition of stimulus-evoked adrenocorticotrophin release caused by suppression of intracellular calcium signals. J Endocrinol. 133:1992;R13-R16.
14. Antoni F A, Lim M C, Smith S M, Grace O C, Paterson J M. Protein kinase C-mediated switch of cyclic AMP responses and glucocorticoid feedback in anterior pituitary cells. British Neuroscience Association Abstracts. 36.05:1999.
15. 2+/calcineurin-inhibited adenylyl cyclase highly abundant in forebrain regions important for learning and memory. J Neurosci. 18:1998;9650-9661.
16. Antoni F A, Smith S M, Simpson J, Rosie R, Fink G, Paterson J M. Calcium control of adenylyl cyclase - The calcineurin connection. Adv Second Messenger Phosphoprotein Res. 32:1998;153-172.
17. Bakalyar H A, Reed R R. Identification of a specialized adenylyl cyclase that may mediate odorant detection. Science. 250:1990;1403-1406.
18. Baker L P, Nielsen M D, Impey S, Hacker B M, Poser S W, Chan M YM, Storm D R. Regulation and immunohistochemical localization of betagamma-stimulated adenylyl cyclases in mouse hippocampus. J Neurosci. 19:1999;180-192.
19. 2+/calmodulin-sensitive adenylyl cyclases by the Gs-coupled 5-hydroxytryptamine subtype 5-HT7A receptor. J Biol Chem. 273:1998;17,469-17,476.
20. Beavo J A. Cyclic-nucleotide phosphodiesterases - Functional implications of multiple isoforms. Physiol Rev. 75:1995;725-748.
21. Bell J D, Buxton I LO, Brunton L L. Enhancement of adenylate cylase activity in S49 lymphoma cells by phorbol esters. J Biol Chem. 260:1985;2625-2628.
22. Beltman J, Sonnenburg W K, Beavo J A. The role of protein phosphorylation in the regulation of cyclic nucleotide phosphodiesterases. Mol Cell Biochem. 127/128:1993;239-253.
23. Berridge M J. The AM and FM of calcium signalling. Nature. 386:1997;759-760.
24. Berridge M J. Neuronal calcium signaling. Neuron. 21:1998;13-26.
25. Böl G F, Gros C, Hulster A, Bosel A, Pfeuffer T. Phorbol ester-induced sensitisation of adenylyl cyclase type II is related to phosphorylation of threonine 1057. Biochem Biophys Res Commun. 237:1997;251-256.
26. Bos J L. All in the family? New insights and questions regarding interconnectivity of Ras, Rap1 and Ral. Embo J. 17:1998;6776-6776.
27. Bos J L. Ras-like GTPases. Biochim Biophys Acta. 1333:1997;M19-31.
28. Cagampang F RA, Antoni F A, Smith S M, Piggins H D, Coen C W. Circadian changes of type II adenylyl cyclase mRNA in the rat suprachiasmatic nuclei. Brain Res Bull. 810:1998;279-282.
29. 2+/calmodulin. J Biol Chem. 271:1996;1089-1095.
30. 2+/calmodulin-stimulated enzyme expressed in discrete regions of rat-brain. J Biol Chem. 269:1994;12,190-12,195.
31. Carvallo P, Aguilera G. Protein kinase C mediates the effect of vasopressin in pituitary corticotrophs. Mol Endocrinol. 3:1989;1935-1943.
32. Chen J, DeVivo M, Dingus J, Harry A, Li J, Sui J, Carty D J, Blank J L, Exton J H, Stoffel R H, Inglese J, Lefkowitz R J, Logothetis D E, Hildebrandt J D, Iyengar R. A region of adenylyl cyclase 2 critical for regulation by G protein βγ subunits. Science. 268:1995;1166-1169.
33. αs stimulation. Proc Natl Acad Sci USA. 94:1997;14,100-14,104.
34. Chik C L, Ho A K, Klein D C. Dual receptor regulation of cyclic-nucleotides - Alpha-1-adrenergic potentiation of vasoactive intestinal peptide stimulation of pinealocyte adenosine-3′,5′-monophosphate. Endocrinology. 122:1988;1646-1651.
35. 2+ channel current in rat pinealocytes: Role of basal phosphorylation. J Neurochem. 72:1999;73-80.
36. (2+)-inhibitable adenylyl cyclase in non-excitable cells. J Biol Chem. 270:1995;1149-1155.
37. Choi E J, Wong S T, Dittman A H, Storm D R. Phorbol ester stimulation of the type I and type III adenylyl cyclases in whole cells. Biochem. 32:1993;1891-1894.
38. Chowdrey H S, Larsen P J, Harbuz M S, Jessop D S, Aguilera G, Eckland D J, Lightman S L. Evidence for arginine vasopressin as the primary activator of the HPA axis during adjuvant-induced arthritis. Br J Pharmacol. 116:1995;2417-2424.
39. Cohen P. Structure and regulation of protein phosphatases. Ann Rev Biochem. 58:1989;453-508.
40. Conti M, Nemoz G, Sette C, Vicini E. Recent progress in understanding the hormonal-regulation of phosphodiesterases. Endocr Rev. 16:1995;370-389.
41. 2+-sensitive adenylyl cyclases. Adv Second Messenger Phosphoprotein Res. 32:1998;23-52.
42. Corcuff J-B, Antaraki A, Simpson J, Antoni F A. Control of adenylyl cyclase by constitutively active signalling pathways. J Endocrinol. 156S:1998;P224.
43. Cronin M J, Summers S T, Sortino M A, Hewlett E L. Protein kinase C enhances growth hormone releasing factor (1-40)-stimulated cyclic AMP levels in anterior pituitary. Actions of somatostatin and pertussis toxin. J Biol Chem. 261:1986;13,932-13,932.
44. Cronin M J, Zysk J R, Baertschi A J. Protein kinase C potentiates corticotropin-releasing factor stimulated cyclic AMP in pituitary cells. Peptides. 7:1986;935-938.
45. Danchin A. Phylogeny of adenylyl cyclases. Adv Second Messenger Phosphoprotein Res. 27:1993;109-162.
46. de Goeij D CE, Dijkstra H, Tilders F JH. Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: Relationship to subordinate status. Endocrinology. 131:1992;847-853.
47. de Rooij J, Zwartkruis F JT, Verheijen M HG, Cool R H, Nijman S MB, Wittinghofer A, Bos J L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature. 396:1998;474-477.
48. DeBernardi M A, Brooker G. Simultaneous fluorescence ratio imaging of cyclic AMP and calcium kinetics in single living cells. Adv Second Messenger Phosphoprotein Res. 32:1998;195-213.
49. Dolmetsch R E, Xu K, Lewis R S. Calcium oscillations increase the efficiency and specificity of gene expression. Nature. 392:1998;933-936.
50. Dessauer C W, Gilman A G. The catalytic mechanism of mammalian adenylyl cyclase. Equilibrium binding and kinetic analysis of P-site inhibition. J Biol Chem. 272:1997;27,787-27,795.
51. Dessauer C W, Gilman A G. Purification and characterization of a soluble form of mammalian adenylyl cyclase. J Biol Chem. 271:1996;16,967-16,974.
52. iα binding site on type V adenylyl cyclase. J Biol Chem. 273:1998;25,831-25,839.
53. Deuster P A, Petrides J S, Singh A, Lucci E B, Chrousos G P, Gold P W. High intensity exercise promotes escape of adrenocorticotropin and cortisol from suppression by dexamethasone: Sexually dimorphic responses. J Clin Endo Metab. 83:1998;3332-3338.
54. 2+ oscillations. Science. 279:1998;227-230.
55. 11α and thyrotropin-releasing hormone receptors proceed on different time scales. J Biol Chem. 273:1998;21,699-21,707.
56. Ewart R BL. Inhibition of anterior-pituitary cyclic-AMP phosphodiesterase by colchicine and vinblastine. FEBS Lett. 141:1982;25-28.
57. 2+-inhibitable adenylyl cyclase in C6-2B glioma cells. J Biol Chem. 274:1999;12,445-12,453.
58. Fisher D A, Smith J F, Pillar J S, St Denis S H, Cheng J B. Isolation and characterization of PDE8A, a novel human cAMP-specific phosphodiesterase. Biochem Biophys Res Commun. 246:1998;570-577.
59. Florio V A, Ross E M. Regulation of the catalytic component of adenylate cyclase. Potentiative interaction of stimulatory ligands and 2′,5′-dideoxyadenosine. Mol Pharmacol. 24:1983;195-202.
60. Gannon M N, Akompong T, Billingsley M L, McEwen B S. Adrenalectomy-induced alterations of calmodulin-dependent hippocampal adenylate cyclase activity: Role of guanine nucleotide-binding proteins. Endocrinology. 134:1994;853-857.
61. Gannon M N, McEwen B S. Calmodulin involvement in stress- and corticosterone-induced down-regulation of cyclic AMP-generating systems in brain. J Neurochem. 55:1990;276-284.
62. Gauss R, Seifert R, Kaupp U B. Molecular identification of a hyperpolarization-activated channel in sea urchin sperm. Nature. 393:1998;583-587.
63. Gilman A G. G-proteins - Transducers of receptor-generated signals. Ann Rev Biochem. 56:1987;615-649.
64. Granneman J G. Expression of adenylyl cyclase subtypes in brown adipose tissue: Neural regulation of type III. Endocrinology. 136:1995;2007-2012.
65. Gu C, Cooper D M. Calmodulin-binding sites on adenylyl cyclase type VIII. J Biol Chem. 274:1999;8012-8021.
66. Hall A. Signal transduction through small GTPases - A tale of two GAPs. Cell. 69:1992;389-391.
67. Hanoune J, Pouille Y, Tzavara E, Shen T S, Lipskaya L, Miyamoto N, Suzuki Y, Defer N. Adenylyl cyclases: Structure, regulation and function in an enzyme superfamily. Mol Cell Endo. 128:1997;179-194.
68. + and A23187. J Biol Chem. 263:1988;9292-9297.
69. Holmes M C, Antoni F A, Catt K J, Aguilera G. Predominant release of vasopressin vs corticotropin releasing factor from the isolated median eminence after adrenalectomy. Neuroendocrinology. 43:1986;245-251.
70. Houslay M D. Adaptation in cyclic AMP signalling processes: A central role for cyclic AMP phosphodiesterases. Sem Cell Develop Biol. 9:1998;161-167.
71. Houslay M D. N-terminal alternately spliced regions of PDE4A cAMP-specific phosphodiesterases determine intracellular targeting and regulation of catalytic activity. Biochem Soc Trans. 24:1996;980-986.
72. Huang C, Duncan J A, Gilman A G, Mumby S M. Persistent membrane association of activated and depalmitoylated G protein alpha subunits. Proc Natl Acad Sci USA. 96:1999;412-417.
73. Hurley J H. Structure, mechanism, and regulation of mammalian adenylyl cyclase. J Biol Chem. 274:1999;7599-7602.
74. Ingram C D, Bicknell R J, Brown D, Leng G. Rapid fatigue of neuropeptide secretion during continual electrical stimulation. Neuroendocrinology. 35:1982;424-428.
75. Ishikawa Y. Regulation of cAMP signaling by phosphorylation. Adv Second Messenger Phosphoprotein Res. 32:1998;99-120.
76. s-stimulated adenylyl cyclases by phorbol ester treatment. J Biol Chem. 268:1993;3829-3832.
77. Jacobowitz O, Iyengar R. Phorbol ester-induced stimulation and phosphorylation of adenylyl cyclase 2. Proc Natl Acad Sci USA. 91:1994;10,630-10,634.
78. Johnson R A, Yeung S M, Stubner D, Bushfield M, Shoshani I. Cation and structural requirements for P site-mediated inhibition of adenylate cyclase. Mol Pharmacol. 35:1989;681-688.
79. 2+ channels by β-aderenergic agonists. Proc Natl Acad Sci USA. 93:1996;295-299.
80. Kawabe J, Ebina T, Toya Y, Oka N, Schwencke C, Duzic E, Ishikawa Y. Regulation of type-V adenylyl-cyclase by PMA-sensitive and PMA-insensitive protein-kinase-C isoenzymes in intact-cells. FEBS Lett. 384:1996;273-276.
81. Kawabe J I, Iwami G, Ebine T, Ohno S, Katada T, Ueda Y, Homcy C J, Ishikawa Y. Differential activation of adenylyl cyclase by protein kinase C isozymes. J Biol Chem. 269:1994;16,554-16,558.
82. Kawasaki H, Springett G M, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman D E, Graybiel A M. A family of cAMP-binding proteins that directly activate Rap1. Science. 282:1998;2275-2279.
83. Kincaid R. Calmodulin-dependent protein phosphatases from microorganisms to man. Adv Second Messenger Phosphoprotein Res. 27:1993;1-23.
84. Klee C B, Cohen P. The calmodulin regulated protein phosphatase. Cohen P, Klee C B. Calmodulin. 1988;225-245 Elsevier, Amsterdam.
85. Klein D C, Coon S L, Roseboom P H, Weller J L, Bernard M, Gastel J A, Zatz M, Iuvone P M, Rodriguez I R, Begay V, Falcon J, Cahill G M, Cassone V M, Baler R. The melatonin rhythm-generating enzyme: Molecular regulation of serotonin N-acetyltransferase in the pineal gland. Rec Prog Horm Res. 52:1997;307-358.
86. 2+-dependent chloride current in mouse pituitary cells. J Physiol (Lond). 439:1991;423-437.
87. Krupinski J, Cali J J. Molecular diversity of the adenylyl cyclases. Adv Second Messenger Phosphoprotein Res. 32:1998;53-79.
88. Krupinski J, Coussen F, Bakalyar H A, Tang W J, Feinstein P G, Orth K, Slaughter C, Reed R R, Gilman A G. Adenylyl cyclase amino acid sequence: Possible channel- or transporter-like structure. Science. 244:1989;1558-1564.
89. Kumari M, Cover P O, Poyser R H, Buckingham J C. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: In vitro and in vivo studies. Br J Pharmacol. 121:1997;459-468.
90. 2a-adenosine receptor-mediated cAMP response. J Biol Chem. 272:1997;4970-4977.
91. 2+/calmodulin binds to and modulates P/Q-type calcium channels. Nature. 399:1999;155-159.
92. Lester L B, Scott J D. Anchoring and scaffold proteins for kinases and phosphatases. Recent Prog Horm Res. 52:1997;409-429.
93. Ludwig A, Zong X G, Jeglitsch M, Hofmann F, Biel M. A family of hyperpolarization-activated mammalian cation channels. Nature. 393:1998;587-591.
94. q. J Biol Chem. 268:1993;13,900-13,905.
95. Ma X M, Lightman S L. The arginine vasopressin and corticotrophin-releasing hormone gene transcription responses to varied frequencies of repeated stress in rats. J Physiol (Lond). 510:1998;605-614.
96. McArthur A J, Hunt A E, Gillette M U. Melatonin action and signal transduction in the rat suprachiasmatic circadian clock: Activation of protein kinase C at dusk and dawn. Endocrinology. 138:1997;627-634.
97. McKee K K, Palyha O C, Feighner S D, Hreniuk D L, Tan C P, Phillips M S, Smith R G, Van der Ploeg L H, Howard A D. Molecular analysis of rat pituitary and hypothalamic growth hormone secretagogue receptors. Mol Endocrinol. 11:1997;415-423.
98. h current in frog melanotrophs. Brain Res Bull. 793:1998;271-278.
99. Milligan G, Mullaney I, Kim G D, MacEwan D. Regulation of the stoichiometry of protein components of the stimulatory adenylyl cyclase cascade. Adv Pharmacol. 42:1998;462-465.
100. 2+-calmodulin-stimulated activity in the hypothalamus. J Neuroendocrinol. 6:1994;665-671.
101. Morrill A C, Wolfgang D, Levine M A, Wand G S. Stress alters adenylyl cyclase activity in the pituitary and frontal cortex of the rat. Life Sci. 53:1993;1719-1727.
102. Nagasaka A, Ohkubo S, Hidaka H. 3′-5′Cyclic-nucleotide phosphodiesterase in the bovine pituitary-gland. Biochim Biophys Acta. 755:1983;481-487.
103. 2+-stimulated adenylyl cyclases by Gi-coupled receptors in vivo. J Biol Chem. 271:1996;33,308-33,316.
104. Paterson J M, Simpson J, Antoni F A. Dephosphorylation of the C1b segment of adenylyl cyclase type 9 by calcineurin. Biochem Soc Trans. 24:1996;583S.
105. Paterson J M, Smith S M, Harmar A J, Antoni F A. Control of a novel adenylyl cyclase by calcineurin. Biochem Biophys Res Commun. 214:1995;1000-1008.
106. Pedarzani P, Storm J F. Protein-kinase A-independent modulation of ion channels in the brain by cyclic-AMP. Proc Natl Acad Sci USA. 92:1995;11,716-11,720.
107. Petrides J S, Mueller G P, Kalogeras K T, Chrousos G P, Gold P W, Deuster P A. Exercise-induced activation of the hypothalamic-pituitary-adrenal axis: Marked differences in the sensitivity to glucocorticoid suppression. J Clin Endo Metab. 79:1994;377-383.
108. Plotsky P M. Pathways to the secretion of adrenocorticotropin: A view from the portal. J Neuroendocrinol. 3:1991;1-9.
109. s in heterologous desensitization: A role for adenosine 3′,5′-monophosphate-dependent phosphorylation. Endocrinology. 131:1992;2774-2784.
110. Premont R T, Matsuoka I, Mattei M-G, Pouille Y, Defer N, Hanoune J. Identification and characterization of a widely expressed form of adenylyl cyclase. J Biol Chem. 271:1996;13,900-13,907.
111. Prosser R A, Gillette M U. Cyclic changes in cAMP concentration and phosphodiesterase activity in a mammalian circadian clock studied in vitro. Brain Res. 568:1991;185-192.
112. 2+ and cAMP messenger system in regulation of airway smooth muscle contraction. Am J Physiol. 258:1990;L279-L288.
113. Rhee M H, Bayewitch M, Avidor-Reiss T, Levy R, Vogel Z. Cannabinoid receptor activation differentially regulates the various adenylyl cyclase isozymes. J Neurochem. 71:1998;1525-1534.
114. 2+-binding domain. J Biol Chem. 273:1998;15,879-15,882.
115. Saito M, Nelson C, Salkoff L, Lingle C J. A cysteine-rich domain defined by a novel exon in a slo variant in rat adrenal chromaffin cells and PC12 cells. J Biol Chem. 272:1997;11,710-11,717.
116. Sakakibara H, Conti M, Weiner R I. Role of phosphodiesterases in the regulation of gonadotropin-releasing hormone secretion in GT1 cells. Neuroendocrinology. 68:1998;365-373.
117. Santoro B, Liu D T, Yao H, Bartsch D, Kandel E R, Siegelbaum S A, Tibbs G R. Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. Cell. 93:1998;717-729.
118. Sarlis N J, Chowdrey H S, Stephanou A, Lightman S L. Chronic activation of the hypothalamo-pituitary-adrenal axis and loss of circadian rhythm during adjuvant-induced arthritis in the rat. Endocrinology. 130:1992;1775-1779.
119. i analysis and biochemical-characterization of pinealocytes immobilized with novel attachment peptide preparation. Brain Res. 614:1993;251-256.
120. Scholich K, Barbier A J, Mullenix J B, Patel T B. Characterisation of soluble forms of non-chimeric type V adenylyl cyclases. Proc Natl Acad Sci USA. 94:1997;2915-2920.
121. sα has properties of a constitutively active receptor [corrected and republished with original paging, article originally printed in J Biol Chem 1998 Feb 27;273(9):5109-1516]. J Biol Chem. 273:1998;5109-5116.
122. Shen T, Suzuki Y, Poyard M, Best-Belpomme M, Defer N, Hanoune J. Localization and differential expression of adenylyl cyclase messenger ribonucleic acids in rat adrenal gland determined by in situ hybridization. Endocrinology. 138:1997;4591-4598.
123. Shipston M J. Mechanism and Modulation of Early Glucocorticoid Inhibition in Anterior Pituitary Corticotrophs. 1992;University of Edinburgh.
124. Shipston M J, Duncan R R, Clark A G, Antoni F A, Tian L. Molecular components of large conductance calcium activated potassium (BK) channels in mouse pituitary corticotropes. Mol Endocrinol. 1999;1728-1737.
125. Shipston M J, Hernando F, Barnard R JO, Antoni F A. Glucocorticoid negative feedback in pituitary corticotropes: Pivotal role for calcineurin inhibition of adenylyl cyclase. Ann N Y Acad Sci. 746:1994;453-455.
126. Shipston M J, Kelly J S, Antoni F A. Glucocorticoids block protein kinase A inhibition of calcium-activated potassium channels. J Biol Chem. 271:1996;9197-9200.
127. Simonneaux V, Kienlen-Campard P, Loeffler J P, Basille M, Gonzalez B J, Vaudry H, Robberecht P, Pevet P. Pharmacological, molecular and functional characterization of vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptors in the rat pineal gland. Neuroscience. 85:1998;887-896.
128. Soderling S H, Bayuga S J, Beavo J A. Cloning and characterization of a cAMP-specific cyclic nucleotide phosphodiesterase. Proc Natl Acad Sci USA. 95:1998;8991-8996.
129. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg P H, Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature. 365:1993;170-175.
130. Sugden D, Klein D C. Activators of protein kinase C act at a postreceptor site to amplify cyclic AMP production in rat pinealocytes. J Neurochem. 50:1988;149-155.
131. Sugden D, Vanecek J, Klein D C, Thomas T P, Anderson W B. Activation of protein kinase-C potentiates isoprenaline-induced cyclic-AMP accumulation in rat pinealocytes. Nature. 314:1985;359-361.
132. Sunahara R K, Dessauer C W, Gilman A G. Complexity and diversity of mammalian adenylyl cyclases. Ann Rev Biochem. 36:1996;461-480.
133. sα. Science. 278:1997;1943-1947.
134. Suprenant A. Correlation between electrical activity and ACTH/β-endorphin secretion in mouse pituitary tumor cells. J Cell Biol. 95:1982;559-566.
135. Sutherland E W. On the biological role of cyclic AMP. Journal of the American Medical Association. 214:1970;1281-1288.
136. Tang W-J, Gilman A G. Type-specific regulation of adenylyl cyclase by G protein βγ subunits. Science. 254:1991;1500-1503.
137. (s)α and forskolin. Science. 268:1995;1769-1772.
138. Tang W J, Krupinski J, Gilman A G. Expression and characterisation of calmodulin-activated (type I) adenylyl cyclase. J Biol Chem. 266:1991;8595-8603.
139. Tang W J, Stanzel M, Gilman A G. Truncation and alanine-scanning mutants of type-I adenylyl-cyclase. Biochem. 34:1995;14,563-14,572.
140. iα. Science. 261:1993;219-221.
141. Taussig R, Tang W-J, Hepler J R, Gilman A G. Distinct patterns of bidirectional regulation of mammalian adenylyl cyclases. J Biol Chem. 269:1994;6093-6100.
142. Taussig R, Zimmermann G. Type-specific regulation of mammalian adenylyl cyclases by G protein pathways. Adv Second Messenger Phosphoprotein Res. 32:1998;81-98.
143. Taylor S S, Knighton D R, Zheng J, Ten Eyck L F, Sowadski J M. Structural framework for the protein kinase family. Annu Rev Cell Biol. 8:1992;429-462.
144. sα.GTPγS. Science. 278:1997;1907-1916.
145. Thrivikraman K V, Plotsky P M. Absence of glucocorticoid negative feedback to moderate hemorrhage in conscious rats. Am J Physiol. 264:1993;E497-E503.
146. Tian L J, Knaus H G, Shipston M J. Glucocorticoid regulation of calcium-activated potassium channels mediated by serine/threonine protein phosphatase. J Biol Chem. 273:1998;13,531-13,536.
147. Toro M J, Montoya E. Calcium dependent phosphodiesterase and its activator (calmodulin) in the rat anterior-pituitary. Acta Endocrinol. 97:1981;349-349.
148. Tzavara E T, Pouille Y, Defer N, Hanoune J. Diurnal variation of the adenylyl cyclase type 1 in the rat pineal gland. Proc Natl Acad Sci USA. 93:1996;11,208-11,212.
149. Vale W, Vaughan J, Smith M, Yamamoto G, Rivier J, Rivier C. Effects of synthetic ovine corticotropin-releasing factor, glucocorticoids, catecholamines, neurohypophysial peptides, and other substances on cultured corticotropic cells. Endocrinology. 113:1983;1121-1128.
150. Vanecek J. Cellular mechanisms of melatonin action. Physiol Rev. 78:1998;687-721.
151. Vita N, Laurent P, Lefort S, Chalon P, Lelias J M, Kaghdad M, Lefur G, Caput D, Ferrara P. Primary structure and functional expression of mouse pituitary and human brain corticotropin-releasing factor receptors. FEBS Lett. 335:1993;1-5.
152. von Bardeleben U, Holsboer F, Stalla G K, Müller O A. Combined administration of human corticotropin-releasing factor and lysine vasopressin induced cortisol escape from dexamethasone suppression in healthy subjects. Life Sci. 37:1985;1613-1618.
153. Vorherr T, Knopfel L, Hofmann F, Mollner S, Pfeuffer T, Carafoli E. The calmodulin-binding domain of nitric oxide synthase and adenylyl cyclase. Biochemistry (USA). 32:1993;6081-6088.
154. 2+ entry is involved in cAMP synthesis in mouse parotid acini. Am J Physiol. 274:1998;C557-C565.
155. 2+ inhibition of type-III adenylyl-cyclase in-vivo. J Biol Chem. 270:1995;21,480-21,486.
156. s-coupled receptors in vivo. J Biol Chem. 269:1994;25,400-25,405.
157. sα. Cell. 77:1994;1063-1070.
158. sα. J Biol Chem. 268:1993;25,001-25,008.
159. Wei J, Zhao A Z, Chan G C, Baker L P, Impey S, Beavo J A, Storm D R. Phosphorylation and inhibition of olfactory adenylyl cyclase by CaM kinase II in neurons: A mechanism for attenuation of olfactory signals. Neuron. 21:1998;495-504.
160. Whisnant R E, Gilman A G, Dessauer C W. Interaction of the 2 cytosolic domains of mammalian adenylyl-cyclase. Proc Natl Acad Sci USA. 93:1996;6621-6625.
161. Wolfgang D, Chen I, Wand G S. Effects of restraint stress on components of adenylyl cyclase signal transduction in the rat hippocampus. Neuropsychopharmacology. 11:1994;187-193.
162. Wu Z, Wong S T, Strom D R. Modification of the calcium and calmodulin sensitivity of the type I adenylyl cyclase by mutagenesis of its calmodulin binding domain. J Biol Chem. 286:1993;23,766-23,768.
163. Xia Z G, Choi E, Wang F, Storm D. The type-III calcium calmodulin-sensitive adenylyl cyclase is not specific to olfactory sensory neurons. Neurosci Lett. 144:1992;169-173.
164. sα activation. J Biol Chem. 272:1997;18,849-18,854.
165. Yau K W. Cyclic nucleotide-gated channels: An expanding new family of ion channels. Proc Natl Acad Sci USA. 91:1994;3481-3483.
166. Yoshimasa T, Sibley D R, Bouvier M, Lefkowitz R J, Caron M G. Cross-talk between cellular signalling pathways suggested by phorbol-ester-induced adenylate cyclase phosphorylation. Nature. 327:1987;67-70.
167. Yoshimura M, Cooper D M. Type-specific stimulation of adenylylcyclase by protein kinase C. J Biol Chem. 268:1993;4604-4607.
168. Yu H J, Ma H, Green R D. Calcium entry via L-type calcium channels acts as a negative regulator of adenylyl cyclase activity and cyclic AMP levels in cardiac myocytes. Mol Pharmacol. 44:1993;689-693.
169. Yuwiler A, Brammer G L, Bennett B L. Interaction between adrenergic and peptide stimulation in the rat pineal: Pituitary adenylate cyclase-activating peptide. J Neurochem. 64:1995;2273-2780.
170. Zhang G, Liu Y, Qin J, Vo B, Tang W J, Ruoho A E, Hurley J H. Characterization and crystallization of a minimal catalytic core domain from mammalian type II adenylyl cyclase. Protein Sci. 6:1997;903-908.
171. Zimmermann G, Taussig R. Protein kinase C alters the responsiveness of adenylyl cyclases to G protein α and βγ subunits. J Biol Chem. 271:1996;27,161-27,166.